News
Good news from biocrates
The latest in metabolomics
In our news section we are dedicted to keeping you informed and enganged with the dynamic world of metabolomics. We deliver information on metabolomics events and webinars, interesting and surprising facts about metabolites, new products, our blog and selected peer-reviewed publications.
Integrated statistics in WebIDQ
New in December 2024
WebIDQ workflow manager now offers statistical tools for data analysis. Eliminate the hassle of exporting data and complete workflows faster with a seamless all-in-one solution combining project management, metabolite quantification, and statistical analysis. Perform descriptive statistics, ANOVA and PCA with clear visual outputs right after metabolite quantification in single, intuitive platform with just a few clicks.
Microbiome and disease | Insights through the lens of the metabolome
Virtual event | January 16, 2025
Join us on January 16 from 04:00 – 05:30 pm to discover how metabolites act as key messengers in microbiome-host communication, influencing health locally and systemically. Learn how metabolomics sheds light on gut-brain, gut-liver, and other gut-organ axes and their roles in diseases from metabolic disorders to mental health. Don’t miss this opportunity to deepen your understanding of these critical pathways.
Metabolite of the month
Oxaloacetic acid
In this section, our scientists look at one specific metabolite each month. Topics of discussion include its implication in various aspects of neurological and cardiovascular health and function. In this month’s article, they take a closer look at oxaloacetic acid.
New multiomics data analysis service
Accelerate biomedical breakthroughs
We are excited to announce that biocrates and VUGENE UAB have partnered to transform multiomics data analysis. This collaboration creates a comprehensive service for efficient multiomics data management, offering life science researchers and clinicians a streamlined solution from data preprocessing to interpretation.
mGWAS
Integrating metabolomics in genome-wide association studies
Combining genome-wide association studies (GWAS) with metabolomics and Mendelian randomization is advancing precision medicine by identifying causal links between genetic variants and clinical outcomes, rather than just correlations. This approach enhances GWAS insights, aiding in the identification of actionable therapeutic targets, but remains underutilized in research.
biocrates YouTube channel
Dedicated to the world of metabolomics
Explore our YouTube channel for a wealth of resources, including technical tutorials, insightful webinars, and our podcast “The Metabolomist”, all dedicated to the world of metabolomics. Whether you’re a beginner or an experienced researcher, our videos and podcasts offer in-depth discussions, practical guidance, and the latest updates in multiomics. Subscribe now to stay informed!
Metabolome and lipidome analysis of human fecal samples
Advancements in analytical techniques and protocols
Check out the latest biocrates application note on human fecal sample analysis, packed with insights into metabolite coverage, stability, and biological variance. The newly updated MxP® Quant 500 kit protocol now features detailed SOPs for both fresh and lyophilized samples. Exciting new innovations are on the horizon —stay tuned for new feces sampling devices and enhanced stability updates!
SMartIDQ alpha
Efficient workflows for busy laboratories
Enhance your lab’s efficiency with the new SMartIDQ alpha kit, a high-throughput, versatile solution for efficient and comprehensive small molecule analysis. Analyze over 100 polar metabolites across 13 biochemical classes. Compatible with various mass spectrometry platforms and matrices.
Revolutionizing Health Assessment and the Future of Personalized Medicine
Coverstory
Recently, biocrates CEO Moritz Seuster discussed the company’s transformative journey and its vision for the future of health in an interview with Insights Care magazine. Read the article in which he highlighted the critical role of metabolomics in reshaping the diagnostics and personalized medicine landscape.
Subscribe to our newsletter
Is this for you?
We compile information on metabolomics on a monthly basis. If you are interested in getting this information first hand via e-mail, please provide your info in the enrolment form.
In case you do not like our format or the content you get delivered, you can unsubscribe at any time.
What happens next?
After entering your name, email address and the captcha you will receive a system-generated email asking you to confirm your subscription. Only after you hit the confirm button from this email you are ready to receive our communications. In case you do not receive the confirmation email, take a look in your spam folder. Sometimes automatically generated emails get sorted wrongly. In case you did not receive the mail, please contact us directly and we sort it out.
